The European Community can bring added value to the actions to be undertaken by Member States in the field of drug prevention and information, including treatment and reduction of drug-related harm, by complementing those actions and by promoting synergies.
Recital 12, Decision_act (EU) 2007/1150
In forcesince 25 Sep 2007